Authors: KUHN JM ABOURACHID H BRUCHER P DOUTRES JC FRETIN J JAUPITRE A JOREST R LAMBERT D PETIT J PIN J BLUMBERG J DUFOURESQUERRE F

Citation: Jm. Kuhn et al., A RANDOMIZED COMPARISON OF THE CLINICAL AND HORMONAL EFFECTS OF 2 GNRH AGONISTS IN PATIENTS WITH PROSTATE-CANCER, European urology, 32(4), 1997, pp. 397-403

Authors: CAPPELAERE P FOURNIER C ROLLAND F MEEUS L DOMENGE C KRAKOWSKI I DEGISLAIN C CHAUVERGNE J DUFOURESQUERRE F PION JM HECQUET B

Citation: P. Cappelaere et al., PREDICTIVE VALUE OF HEMATOLOGICAL COUNTS AT THE 4TH DAY AFTER CARBOPLATIN-FLUOROURACIL REGIMEN FOR NEUTRO AND OR THROMBOPENIA/, Bulletin du cancer, 83(7), 1996, pp. 559-565

Authors: MAULARD C RICHAUD P DROZ JP JESSUELD D DUFOURESQUERRE F HOUSSET M

Citation: C. Maulard et al., PHASE I-II STUDY OF THE SOMATOSTATIN ANALOG LANREOTIDE IN HORMONE-REFRACTORY PROSTATE-CANCER, Cancer chemotherapy and pharmacology, 36(3), 1995, pp. 259-262

Authors: CAPPELAERE P HECQUET B ROLLAND F MEEUS L DOMENGE C KRAKOWSKI I DEGISLAIN C CHAUVERGNE J DUFOURESQUERRE F CARDE P

Citation: P. Cappelaere et al., RANDOMIZED TRIAL OF MYELOPREVENTION BY GORALATINE VS PLACEBO FOR PATIENTS WITH HEAD AND NECK SQUAMOUS-CELL CARCINOMA, TREATED BY CARBOPLATIN-FLUOROUROCILE, Bulletin du cancer, 82(9), 1995, pp. 732-737